Biochemical response to substrate reduction therapy versus enzyme replacement therapy in Gaucher disease type 1 patients

  • Smid B
  • Ferraz M
  • Verhoek M
 et al. 
  • 29


    Mendeley users who have this article in their library.
  • 15


    Citations of this article.


BACKGROUND: We retrospectively compared biochemical responses in type 1 Gaucher disease patients to treatment with glycosphingolipid synthesis inhibitors miglustat and eliglustat and ERT.

METHODS: Seventeen GD1 patients were included (n = 6 eliglustat, (two switched from ERT), n = 9 miglustat (seven switchers), n = 4 ERT (median dose 60U/kg/m). Plasma protein markers reflecting disease burden (chitotriosidase, CCL18) and lipids reflecting substrate accumulation (glucosylsphingosine, glucosylceramide) were determined. Also, liver and spleen volumes, hemoglobin, platelets, and fat fraction were measured.

RESULTS: In patients naïve to treatment, chitotriosidase, CCL18 and glucosylsphingosine decreased comparably upon eliglustat and ERT treatment, while the response to miglustat was less. After 2 years, median decrease of chitotriosidase was 89 % (range 77-98), 88 % (78-92) and 37 % (29-46) for eliglustat, ERT and miglustat naïve patients respectively; decrease of CCL18 was 73 % (63-78), 54 % (43-86), and 10 % (3-18); decrease of glucosylsphingosine was 86 % (78-93), 78 % (65-91), 48 % (46-50). Plasma glucosylceramide in eliglustat treated patients (n = 4) reached values below the normal range (n = 20 healthy controls). Biochemical markers decreased or stabilized in switchers from ERT to eliglustat (n = 2), but less in miglustat switchers (n = 7). Clinical parameters responded comparably upon eliglustat and ERT treatment.

CONCLUSIONS: Our explorative study provides evidence that biochemical markers respond comparably in patients receiving eliglustat treatment and ERT, while the corresponding response to miglustat treatment is less.

Author-supplied keywords

  • Chitotriosidase
  • Eliglustat
  • Enzyme replacement therapy
  • Gaucher disease
  • Glucosylceramide
  • Glucosylsphingosine
  • Miglustat

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Bouwien E. Smid

  • Maria J. Ferraz

  • Marri Verhoek

  • Mina Mirzaian

  • Patrick Wisse

  • Herman S. Overkleeft

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free